Recent evidence of distributed additive manufacturing networks revolutionizing supply chains to meet drastic, sudden shifts in demand for life-saving medical equipment in times of a global pandemic makes evident that additive manufacturing technologies are at a tipping point of enabling local, on-demand, fit-for-purpose manufacturing that transforms societies. 

Douglas Friedman's topic is Synthetic Biology and BioMADE

Tim Bell's topic is: "Digitalization for AM — How to Leverage Digitalization in AM Operations"

Marco Zani's specific topic is TBA, however the subject is focused on Additive Manufacturing

Olav Lyngberg, PhD. will discuss Monoclonal Antibody Manufacturing: Transforming Our Most Important Biologics Manufacturing Process from an Artform to a Science

Moneer Helu, Ph.D. will discuss Model-Based Manufacturing and Smart Manufacturing Systems Test Bed at NIST